Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Expert
Innovation Services
About Index
Index
By TNW
Log in
Register
Stoke Therapeutics
3000
Stoke Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.
Suggest edits
Type
B2b
Founded
2017
Raised
$40M
Follow us
Companies in the same industry
Neuronetics, Inc.
Seattle Genetics
Denali Therapeutics
PeptiMimesis
Brainvectis
Immunic AG
Methylation Sciences
Arsia Therapeutics
Caldan Therapeutics
Chordia Therapeutics
Alexa global traffic share
